Frontiers | Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of
Monoclonal antibodies specific to human Δ42PD1: A novel immunoregulator potentially involved in HIV-1 and tumor pathogenesis
Frontiers | Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB
A Comparison of Murine PD-1 and PD-L1 Monoclonal Antibodies | Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
CEP170 Monoclonal Antibody (72-413-1) (41-3200)
Molecular basis of PD-1 blockade by dostarlimab, the FDA-approved antibody for cancer immunotherapy - ScienceDirect
Frontiers | Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB
Frontiers | Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of
Immunohistochemical staining. H. pylori-infected gastric biopsy... | Download Scientific Diagram
Kappa (a) and lambda (b) mRNA by in situ hybridization (showing... | Download Scientific Diagram
Development and characterization of anti-IL-5 monoclonal antibody Fab fragment for blocking IL-5/IL-5Rα binding - ScienceDirect
Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients | Cell Death & Disease
Development and characterization of anti-IL-5 monoclonal antibody Fab fragment for blocking IL-5/IL-5Rα binding - ScienceDirect
The development of immunomodulatory monoclonal antibodies as a new therapeutic modality for cancer: The Bristol-Myers Squibb experience - ScienceDirect
CEP170 Monoclonal Antibody (72-413-1) (41-3200)
Frontiers | Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB
Frontiers | Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of
FOXP3 Monoclonal Antibody (FJK-16s), APC (17-5773-82)
Development and characterization of anti-IL-5 monoclonal antibody Fab fragment for blocking IL-5/IL-5Rα binding - ScienceDirect
Molecules | Free Full-Text | Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy
Gastrointestinal stability of therapeutic anti-TNF α IgG1 monoclonal antibodies - ScienceDirect
